MagnetisMM-3 trial: Patient-reported outcomes following treatment with elranatamab
Here, we summarize a publication by Mohty et al. in the British Journal of Haematology on patient-reported outcomes following treatment with elranatamab in the phase II MagnetisMM-3 clinical trial.